← Open Payments lookup

NPI 1831129394: Open Payments

NPI 1831129394. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$40 in 2 payments from 2 companies in 2025. Trend: 2023 $735 · 2024 $240 · 2025 $40

Food & beverage: $40
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.1$25
Axsome Therapeutics, Inc.1$15

Products named: INGREZZA, Auvelity.